Prognostic Factors and a Nomogram Predicting Survival in Patients with Breast Ductal Carcinoma in situ with Microinvasion: A Population-Based Study.

Yi-Zi ZhengHong-Bin QinZi-Zheng LiHe-Sheng JiangGreg ZhangShi-Wei YangXian-Ming WangYang-Chun XuZhenghan DengGuo-Wen Liu

Published in: Clinical epidemiology (2021)

Our current study is the first to construct nomograms of patients with DCISM which could help physicians identify breast cancer patients that more likely to benefit from more intensive treatment and follow-up. Chemotherapy might benefit patients with ER-PR- and ER+PR-/ER-PR+ DCISM.

Keyphrases

prognostic factors
endoplasmic reticulum
estrogen receptor
breast cancer cells
primary care
lymph node metastasis
radiation therapy
combination therapy
replacement therapy
rectal cancer